Supply of Tobramycin and Dexamethasone Ophthalmic Medication

The contract specifies the supply and delivery of two treatment units of FDA-approved Tobramycin and Dexamethasone Ophthalmic medication, identified by NDC 00078-0876-01, intended for distribution to Fort Bragg, North Carolina. The medication is a combination antibiotic and corticosteroid used for treating ocular infections and inflammation, and its procurement adheres to federal regulatory standards for pharmaceuticals. The contract is classified as a subcontract under the NAICS code 325412, which corresponds to pharmaceutical and biological product manufacturing, indicating the involvement of a manufacturer or distributor in the supply chain. Issued by the Defense Logistics Agency under the Department of Defense, the contract was posted on July 15, 2026, and is associated with the award contract number SPE2DX25D9900 and delivery order SPE2DP26F7713. While the solicitation number and set-aside details are not provided, the place of performance and delivery location are clearly designated as Fort Bragg, NC, ensuring the medication reaches military medical facilities supporting service members. The contract’s structure suggests a direct logistical flow from the supplier to the end-use location, with no intermediary procurement steps indicated, and all activities are governed under the contractual framework managed by DLA’s procurement systems.